Hauptseite > Publikationsdatenbank > Evidence of the Sensitivity of the MoCA Alternate Forms in Monitoring Cognitive Change in Early Alzheimer's Disease > print |
001 | 201255 | ||
005 | 20210129215708.0 | ||
024 | 7 | _ | |a 10.1159/000351864 |2 doi |
024 | 7 | _ | |a 1013-7424 |2 ISSN |
024 | 7 | _ | |a 1420-8008 |2 ISSN |
024 | 7 | _ | |a 1421-9824 |2 ISSN |
024 | 7 | _ | |a WOS:000331808200009 |2 WOS |
037 | _ | _ | |a FZJ-2015-03560 |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Costa, Ana Sofia |0 P:(DE-HGF)0 |b 0 |
245 | _ | _ | |a Evidence of the Sensitivity of the MoCA Alternate Forms in Monitoring Cognitive Change in Early Alzheimer's Disease |
260 | _ | _ | |a Basel |c 2014 |b Karger |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1433832583_26782 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a article |2 DRIVER |
520 | _ | _ | |a Background/Aims: There is an increasing interest in using the Montreal Cognitive Assessment (MoCA) test as a monitoring tool in Alzheimer's disease (AD) in both research and clinical settings. Our aim was to investigate the utility of alternate forms of the MoCA in detecting cognitive deterioration in a sample of early AD patients followed longitudinally in an outpatient memory clinic. Method: Twenty-five patients with early-stage AD (prodromal or mild dementia) were administered the original version and one of two previously validated alternate forms of the MoCA within an interval of about 1 year. The decline over time and the rate of change of the MoCA were compared to the total score of a standardized neuropsychological assessment battery (Consortium to Establish a Registry of Alzheimer's Disease; CERAD-Plus). Responsiveness to change was determined by calculating standard response means and the respective effect sizes. Results: Sixty percent of the sample showed a clinical decline on the clinical dementia rating (CDR) scale. There was significant deterioration in the MoCA and CERAD total scores. Conclusion: The results demonstrate that the MoCA is capable of detecting change over time and seems to be a valid tool with small to moderate sensitivity for monitoring cognitive change in early AD. |
536 | _ | _ | |a 332 - Imaging the Living Brain (POF2-332) |0 G:(DE-HGF)POF2-332 |c POF2-332 |f POF II |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, juser.fz-juelich.de |
700 | 1 | _ | |a Reich, Arno |0 P:(DE-HGF)0 |b 1 |
700 | 1 | _ | |a Fimm, Bruno |0 P:(DE-HGF)0 |b 2 |
700 | 1 | _ | |a Ketteler, Simon Thomas |0 P:(DE-HGF)0 |b 3 |
700 | 1 | _ | |a Schulz, Joerg Bernhard |0 P:(DE-HGF)0 |b 4 |
700 | 1 | _ | |a Reetz, Kathrin |0 P:(DE-Juel1)162203 |b 5 |e Corresponding Author |
773 | _ | _ | |a 10.1159/000351864 |g Vol. 37, no. 1-2, p. 95 - 103 |0 PERI:(DE-600)1482186-2 |n 1-2 |p 95 - 103 |t Dementia and geriatric cognitive disorders |v 37 |y 2014 |x 1421-9824 |
856 | 4 | _ | |u https://juser.fz-juelich.de/record/201255/files/351864.pdf |y Restricted |
856 | 4 | _ | |u https://juser.fz-juelich.de/record/201255/files/351864.gif?subformat=icon |x icon |y Restricted |
856 | 4 | _ | |u https://juser.fz-juelich.de/record/201255/files/351864.jpg?subformat=icon-1440 |x icon-1440 |y Restricted |
856 | 4 | _ | |u https://juser.fz-juelich.de/record/201255/files/351864.jpg?subformat=icon-180 |x icon-180 |y Restricted |
856 | 4 | _ | |u https://juser.fz-juelich.de/record/201255/files/351864.jpg?subformat=icon-640 |x icon-640 |y Restricted |
856 | 4 | _ | |u https://juser.fz-juelich.de/record/201255/files/351864.pdf?subformat=pdfa |x pdfa |y Restricted |
909 | C | O | |o oai:juser.fz-juelich.de:201255 |p VDB |
910 | 1 | _ | |a Forschungszentrum Jülich GmbH |0 I:(DE-588b)5008462-8 |k FZJ |b 5 |6 P:(DE-Juel1)162203 |
913 | 2 | _ | |a DE-HGF |b Key Technologies |l Decoding the Human Brain |1 G:(DE-HGF)POF3-570 |0 G:(DE-HGF)POF3-573 |2 G:(DE-HGF)POF3-500 |v Neuroimaging |x 0 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Funktion und Dysfunktion des Nervensystems |1 G:(DE-HGF)POF2-330 |0 G:(DE-HGF)POF2-332 |2 G:(DE-HGF)POF2-300 |v Imaging the Living Brain |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF2 |
914 | 1 | _ | |y 2015 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Thomson Reuters Master Journal List |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |
915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |
920 | 1 | _ | |0 I:(DE-Juel1)INM-4-20090406 |k INM-4 |l Physik der Medizinischen Bildgebung |x 0 |
920 | 1 | _ | |0 I:(DE-82)080010_20140620 |k JARA-BRAIN |l JARA-BRAIN |x 1 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-Juel1)INM-4-20090406 |
980 | _ | _ | |a I:(DE-82)080010_20140620 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|